SGLT2 inhibitors and GLP-1 receptor agonists are used in patients with type 2 diabetes as
glucose lowering therapies, with additional benefits of weight loss and blood pressure …

Purpose Diabetic peripheral neuropathy (DPN) is the commonest cause of neuropathy
worldwide, and its prevalence increases with the duration of diabetes. It affects …

Background: Although the health benefits of regular physical activity and exercise are well
established and have been incorporated into national public health recommendations, there …

Objective To assess medium-term organ impairment in symptomatic individuals following
recovery from acute SARS-CoV-2 infection. Design Baseline findings from a prospective …

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with
type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and …

Context: Nonalcoholic fatty liver disease may be evident in women with polycystic ovary
syndrome (PCOS), both conditions being associated with obesity and insulin resistance …

Background: Cushing's syndrome (CS) is a severe condition with excess mortality and
significant morbidity necessitating control of hypercortisolemia. There are few data …

Carcinoid heart disease is a frequent occurrence in patients with carcinoid syndrome and is
responsible for substantial morbidity and mortality. The pathophysiology of carcinoid heart …

We hypothesized a differential activation of the anabolic signaling proteins protein kinase B
(PKB) and p70 S6 kinase (p70S6K) and subsequent differential stimulation of human …

We are facing a global epidemic of obesity and type 2 diabetes. Weight loss, in the context of
obesity and type 2 diabetes, may improve glycaemic control and weight‐related …